Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | PPIB | P23284 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.31 |
| ▸ | PPIA | P62937 | 1/20 | 0.31 |
| ▸ | PPID | Q08752 | 1/20 | 0.31 |
| ▸ | PPIG | Q13427 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24016441 | 0.75 | SMN1; SMN2 (0.34) | LSSSMN1; SMN2EPHX2HPGDPPIB | |
| SCHEMBL14619100 | 0.73 | PPIB (0.43) | TSHREPHX2PRSS1TPSAB1PPIB | |
| SCHEMBL24016387 | 0.71 | HPGD (0.38) | HPGD | |
| SCHEMBL7670360 | 0.64 | ESR1 (0.38) | TSHR | |
| SCHEMBL14472553 | 0.63 | EPHX2 (0.44) | SMN1; SMN2TSHREPHX2TPSAB1PPIB | |
| SCHEMBL26028796 | 0.62 | GRB2 (0.45) | — | |
| Tert-Butylamine SCHEMBL27931811 | 0.61 | L3MBTL1 (0.66) | LSSSMN1; SMN2EPHX2HPGDCA2 | |
| SCHEMBL10570 | 0.61 | ALDH1A1 (0.52) | TSHR | |
| SCHEMBL25343430 | 0.60 | ESR1 (0.43) | LMNA | |
| SCHEMBL25342534 | 0.60 | SLC6A2 (0.61) | HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021224680-A1 | SUBSTITUTED BENZOTRIAZINONE METABOLITES OF A GPR139 AGONIST | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-11-11 | — | — | WO | disclosed |